BG105664A - Use of apomophines for the treatment of organic erectile dysfunction in males - Google Patents

Use of apomophines for the treatment of organic erectile dysfunction in males

Info

Publication number: BG105664A
Authority: BG; Bulgaria
Prior art keywords: erectile dysfunction; treatment; apomophines; males; organic erectile
Prior art date: 1998-12-17

Application number

BG105664A

Other languages

Bulgarian (bg)

English (en)

Inventor

Karen Kling

Renee PERDOK

Dustin RUFF

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-17

Filing date

2001-07-03

Publication date

2002-02-28

2001-07-03 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

2002-02-28 Publication of BG105664A publication Critical patent/BG105664A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)

BG105664A 1998-12-17 2001-07-03 Use of apomophines for the treatment of organic erectile dysfunction in males BG105664A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/213,567 US6291471B1 (en)	1998-12-17	1998-12-17	Use of apomorphine for the treatment of organic erectile dysfunction in males
PCT/US1999/029449 WO2000035457A1 (en)	1998-12-17	1999-12-13	Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males

Publications (1)

Publication Number	Publication Date
BG105664A true BG105664A (en)	2002-02-28

Family

ID=22795606

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG105664A BG105664A (en)	1998-12-17	2001-07-03	Use of apomophines for the treatment of organic erectile dysfunction in males

Country Status (22)

Country	Link
US (1)	US6291471B1 (xx)
EP (1)	EP1140094A1 (xx)
JP (1)	JP2003521462A (xx)
KR (1)	KR20010101241A (xx)
CN (1)	CN1335772A (xx)
AR (1)	AR021912A1 (xx)
AU (1)	AU2175800A (xx)
BG (1)	BG105664A (xx)
BR (1)	BR9916114A (xx)
CA (1)	CA2354601A1 (xx)
CZ (1)	CZ20012084A3 (xx)
HK (1)	HK1043303A1 (xx)
HU (1)	HUP0201618A3 (xx)
IL (1)	IL143410A0 (xx)
NO (1)	NO20012985L (xx)
NZ (1)	NZ511790A (xx)
PL (1)	PL354920A1 (xx)
SK (1)	SK8262001A3 (xx)
TR (1)	TR200101719T2 (xx)
TW (1)	TW577740B (xx)
WO (1)	WO2000035457A1 (xx)
ZA (1)	ZA200104146B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6566368B2 (en) *	1994-04-22	2003-05-20	Pentech Pharmaceuticals, Inc.	Apomorphine-containing dosage form for ameliorating male erectile dysfunction
BR0005797A (pt) *	2000-03-20	2001-10-16	Abbott Lab	Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
BR0110450A (pt) *	2000-11-22	2005-02-09	Abbott Lab	Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual
WO2002062315A1 (en) *	2001-02-08	2002-08-15	Pharmacia Corporation	Rapid-onset medicament for the treatment of sexual dysfunction
EP1496915A1 (en) *	2002-03-19	2005-01-19	Brain 'N' Beyond Biotech	Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
SE0202365D0 (sv)	2002-08-05	2002-08-05	Pharmacia Ab	New formulation and use thereof
US20040204439A1 (en) *	2003-04-14	2004-10-14	Staniforth John Nicholas	Composition, device, and method for treating sexual dysfunction via inhalation
WO2004089374A1 (en) *	2003-04-14	2004-10-21	Vectura Ltd	Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
AU2005232748A1 (en)	2004-04-13	2005-10-27	The Mclean Hospital Corporation	R(-)-11-hydroxyaporphine derivatives and uses thereof
GB2437488A (en) *	2006-04-25	2007-10-31	Optinose As	Pharmaceutical oily formulation for nasal or buccal administration
US8431591B2 (en) *	2007-07-12	2013-04-30	The Mclean Hospital Corporation	R(−)-2-methoxy-11-hydroxyaporphine and derivatives thereof
BRPI0800596A2 (pt)	2008-01-31	2009-09-22	Univ Minas Gerais	método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer
CN102316875A (zh)	2009-02-13	2012-01-11	贝林格尔.英格海姆国际有限公司	用于治疗i型糖尿病、ii型糖尿病、葡萄糖耐量降低或高血糖症的sglt-2抑制剂
KR101890317B1 (ko)	2010-12-16	2018-08-22	선오비온 파마슈티컬스 인코포레이티드	설하 필름
KR101374500B1 (ko) *	2012-10-09	2014-03-13	울산대학교 산학협력단	Ｒ(-)-프로필노르아포모르핀을 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
HK1213818A1 (zh)	2013-04-05	2016-07-15	勃林格殷格翰国际有限公司	依帕列净的治疗用途
ES2702174T3 (es)	2013-04-05	2019-02-27	Boehringer Ingelheim Int	Usos terapéuticos de empagliflozina
CA2812519A1 (en)	2013-04-05	2014-10-05	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
DK2986304T3 (da)	2013-04-18	2022-04-04	Boehringer Ingelheim Int	Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf.
EP3288561B1 (en) *	2015-04-30	2021-03-31	Boehringer Ingelheim International GmbH	Methods and pharmaceutical compositions comprising a sglt2 inhibitor for treating or improving erectile dysfunction
WO2017168174A1 (en)	2016-04-02	2017-10-05	N4 Pharma Uk Limited	New pharmaceutical forms of sildenafil
CN109922813A (zh)	2016-11-10	2019-06-21	勃林格殷格翰国际有限公司	药物组合物、治疗方法及其用途
EP3807897A1 (en) *	2018-06-14	2021-04-21	AstraZeneca UK Limited	Methods for treating erectile dysfunction with a cgmp-specific phosphodiesterase 5 inhibitor pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5256652A (en)	1987-11-12	1993-10-26	Pharmedic Co.	Topical compositions and methods for treatment of male impotence
US5270323A (en)	1990-05-31	1993-12-14	Pfizer Inc.	Method of treating impotence
US5292520A (en)	1990-09-13	1994-03-08	Akzo N.V.	Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
ATE241984T1 (de)	1993-03-26	2003-06-15	Franciscus Wilhelmus He Merkus	Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
PT758895E (pt) *	1994-04-22	2000-05-31	Univ Kingston	Formas de dosagem sublingual contendo apomorfina para uso no tratamento da disfuncao erectil
US5562917A (en)	1994-12-23	1996-10-08	Pentech Pharmaceuticals, Inc.	Transdermal administration of apomorphine
US5888534A (en)	1995-06-13	1999-03-30	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
US5624677A (en) *	1995-06-13	1997-04-29	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
US5688499A (en)	1996-03-13	1997-11-18	Queen's University At Kingston	Antagonism of endothelin actions
DE19652268C2 (de)	1996-12-16	2000-06-29	Lohmann Therapie Syst Lts	Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle

1998
- 1998-12-17 US US09/213,567 patent/US6291471B1/en not_active Expired - Fee Related
1999
- 1999-12-13 PL PL99354920A patent/PL354920A1/xx not_active Application Discontinuation
- 1999-12-13 TR TR2001/01719T patent/TR200101719T2/xx unknown
- 1999-12-13 SK SK826-2001A patent/SK8262001A3/sk unknown
- 1999-12-13 EP EP99966147A patent/EP1140094A1/en not_active Withdrawn
- 1999-12-13 CN CN99814559A patent/CN1335772A/zh active Pending
- 1999-12-13 NZ NZ511790A patent/NZ511790A/en unknown
- 1999-12-13 CA CA002354601A patent/CA2354601A1/en not_active Abandoned
- 1999-12-13 IL IL14341099A patent/IL143410A0/xx unknown
- 1999-12-13 HK HK02102415.1A patent/HK1043303A1/zh unknown
- 1999-12-13 BR BR9916114-1A patent/BR9916114A/pt not_active IP Right Cessation
- 1999-12-13 JP JP2000587777A patent/JP2003521462A/ja not_active Withdrawn
- 1999-12-13 CZ CZ20012084A patent/CZ20012084A3/cs unknown
- 1999-12-13 AU AU21758/00A patent/AU2175800A/en not_active Abandoned
- 1999-12-13 HU HU0201618A patent/HUP0201618A3/hu unknown
- 1999-12-13 WO PCT/US1999/029449 patent/WO2000035457A1/en not_active Ceased
- 1999-12-13 KR KR1020017007500A patent/KR20010101241A/ko not_active Ceased
- 1999-12-17 AR ARP990106551A patent/AR021912A1/es not_active Application Discontinuation
2000
- 2000-01-11 TW TW088122257A patent/TW577740B/zh not_active IP Right Cessation
2001
- 2001-05-21 ZA ZA200104146A patent/ZA200104146B/xx unknown
- 2001-06-15 NO NO20012985A patent/NO20012985L/no not_active Application Discontinuation
- 2001-07-03 BG BG105664A patent/BG105664A/xx unknown

Also Published As

Publication number	Publication date
NO20012985L (no)	2001-08-16
PL354920A1 (en)	2004-03-22
KR20010101241A (ko)	2001-11-14
AU2175800A (en)	2000-07-03
ZA200104146B (en)	2002-08-21
NO20012985D0 (no)	2001-06-15
EP1140094A1 (en)	2001-10-10
HK1043303A1 (zh)	2002-09-13
BR9916114A (pt)	2003-01-14
HUP0201618A3 (en)	2003-03-28
CN1335772A (zh)	2002-02-13
CA2354601A1 (en)	2000-06-22
JP2003521462A (ja)	2003-07-15
WO2000035457A1 (en)	2000-06-22
HUP0201618A2 (en)	2002-09-28
IL143410A0 (en)	2002-04-21
US6291471B1 (en)	2001-09-18
SK8262001A3 (en)	2002-01-07
CZ20012084A3 (cs)	2002-01-16
AR021912A1 (es)	2002-09-04
TR200101719T2 (tr)	2002-08-21
TW577740B (en)	2004-03-01
NZ511790A (en)	2004-04-30

Publication	Publication Date	Title
BG105664A (en)	2002-02-28	Use of apomophines for the treatment of organic erectile dysfunction in males
MY119375A (en)	2005-05-31	Treatment of tinnitus using neuroprotective agents
BE2012C040I2 (xx)	2019-10-16
MY130727A (en)	2007-07-31	Controlled-release pharmaceutical formulations
MY118526A (en)	2004-11-30	Method for improving the pharmacokinetics of tipranavir
BR9911060A (pt)	2001-02-06	Composições compreendendo mono- ou dinitrato orgânico para tratar impotência
UA41355C2 (uk)	2001-09-17	Засіб для лікування нейро-сніду
AU1711197A (en)	1997-08-20	Method for treating sexual dysfunctions
EP1108426A3 (en)	2002-10-02	Use of prostaglandin agonists to treat erectile dysfunction or impotence
IL143985A0 (en)	2002-04-21	New use of melagatran
WO1999065475A3 (en)	2000-04-06	Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
WO2000053148A3 (en)	2000-12-14	Methods and compositions for treating erectile dysfunction
BG106209A (en)	2002-09-30	Therapeutic agents
MX9604692A (es)	1998-04-30	Derivados de quinoxalina para el tratamiento de tinnitus.
IL146962A0 (en)	2002-08-14	Aminotetralin derivatives for the therapy of cardiovascular diseases
RU93058537A (ru)	1996-10-10	Применение атипамезола для лечения мужской сексуальной импотенции
WO1995005364A3 (en)	1995-03-23	Inhibitors of biogenic amine transporters
HK1039057A (en)	2002-04-12	Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males
NO304011B1 (no)	1998-10-12	Anvendelse av atipamezol til fremstilling av et medisinsk preparat for behandling av menns impotens
US6541495B1 (en)	2003-04-01	Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
AU4918900A (en)	2000-11-14	Interferon-beta use in the treatment of ewing's family of tumors
ZA200006378B (en)	2002-05-06	Compounds for the treatment of female sexual dysfunction.